4.3 Editorial Material

Rationale for IL-15 superagonists in cancer immunotherapy

Journal

EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 20, Issue 7, Pages 705-709

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/14712598.2020.1738379

Keywords

IL-15 superagonist; NK cells; CD8 T cells; immune activation

Funding

  1. Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available